MSLN and pancreatic adenocarcinoma: MSLN shows significant overexpression in multiple malignancies, including ovarian cancer, mesothelioma, pancreatic adenocarcinoma, and non-small cell lung cancer, and MSLN is expressed at low levels in normal tissues (31, 32).